Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
Newsletters
Podcasts
more
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SIGN IN
Subscribe Now
Johnson & Johnson
16 pages
Health
Johnson & Johnson is paying $17.3 billion to buy a company that helps your heart pump blood
BY
Madison Muller
and
Bloomberg
November 1, 2022
Conferences
Chief diversity officers on the key to leveling the corporate playing field
BY
Kristine Gill
September 16, 2022
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
BY
Paige McGlauflin
August 15, 2022
Health
Johnson & Johnson to stop selling talc-based baby powder as cancer lawsuits pile on
BY
Riley Griffin
,
Jef Feeley
, and others
August 11, 2022
Newsletters
The wisdom of J&J’s Alex Gorsky
BY
Alan Murray
and
David Meyer
June 10, 2022
Finance
Musk claims S&P ‘lost their integrity’ after Tesla gets booted from sustainability index while Exxon is included
BY
Christiaan Hetzner
May 18, 2022
Health
FDA restricts Johnson & Johnson’s COVID-19 vaccine to people 18 and older due to blood clot risk
BY
Matthew Perrone
,
Lauran Neergaard
, and others
May 5, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
BY
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Health
The weird case of Novavax’s falling stock price: The vaccine that might be big news for the vax hesitant
BY
Andrew Marquardt
March 15, 2022
Magazine
Apple, Walt Disney, and UnitedHealth have this in common: Their business rivals give them ultra-high performance scores
BY
Matthew Heimer
and
Scott DeCarlo
February 2, 2022
Health
With Omicron dominant, new COVID cases are up 254%—and those are just the reported ones
BY
Erika Fry
and
Nicolas Rapp
January 5, 2022
Health
A Johnson & Johnson booster reduces Omicron hospitalizations by up to 85%, says a new South African study
BY
Michelle Fay Cortez
and
Bloomberg
December 30, 2021
Health
Moderna hit by shareholders who want to know why its COVID-19 vaccine is so expensive and unavailable in poorer countries
BY
David Meyer
December 27, 2021
Health
J&J, Sputnik, and Sinopharm vaccines found to be largely ineffective in fighting Omicron: study
BY
Bloomberg
December 17, 2021
Newsletters
Stocks and crypto falter, looking set to close out the week on a losing streak
BY
Bernhard Warner
December 17, 2021
Most Popular
Life
Waking up at 5 a.m. every day could improve your life—here’s how to make it work for you
January 29, 2023
BY
Alexa Mikhail
Finance
Housing market slump gives homebuilders no choice but to offer aggressive mortgage rate buydowns
January 31, 2023
BY
Alena Botros
Finance
‘It really disturbs me to say this, but I think I agree with Larry.’ Paul Krugman is with his frenemy Larry Summers on...
January 31, 2023
BY
Nicholas Gordon
1 - 15 of 234 results
1
2
3
...
16
Next Page